American Journal of Ophthalmology
Volume 125, Issue 6 , Pages 745-766 , June 1998

Histopathologic characteristics of uveal melanomas in eyes enucleated from the collaborative ocular melanoma study COMS report no. 6

  • Collaborative Ocular Melanoma Study Group

      Affiliations

    • Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, Madison, Wisconsin, USA (Dr Albert and Ms Robinson)
    • Department of Biostatistics (Dr Diener-West), Johns Hopkins University, Baltimore, Maryland, USA
    • Department of Ophthalmology, Emory University, Atlanta, Georgia, USA (Dr Grossniklaus)
    • Department of Ophthalmology (Drs Diener-West and Green), Johns Hopkins University, Baltimore, Maryland, USA
    • Corresponding Author InformationCorrespondence to Daniel M. Albert, MD, Department of Ophthalmology and Visual Sciences, University of Wisconsin Medical School, F4/338 CSC, 600 Highland Ave, Madison, WI 53792-3220; fax: (608) 263-1466
    • albert@eyesee.ophth.wisc.edu

,Accepted 13 October 1997.

References 

  1. Callender GR. Malignant melanotic tumors of the eye (a study of histologic types in 111 cases). Trans Am Acad Ophthalmol Otolaryngol. 1931;36:131–142
  2. Callender GR, Wilder HC, Ash JE. Five hundred melanomas of the choroid and ciliary body followed five years or longer. Am J Ophthalmol. 1942;25:562–567
  3. Flocks M, Gerende JH, Zimmerman LE. The size and shape of malignant melanoma of the choroid and ciliary body in relation to prognosis and histologic characteristics (a statistical study of 210 tumors). Trans Am Acad Ophthalmol Otolaryngol. 1955;59:740–756
  4. Jensen OA. Malignant melanoma of the human uvea. Acta Ophthalmologica. 1963;75(suppl):17–215
  5. Raivio I. Uveal melanomas in Finland (an epidemiological, clinical, histological, and prognostic study). Acta Ophthalmol. 1977;133(suppl):1–64
  6. Shammas HF, Blodi FC. Prognostic factors in choroidal and ciliary body melanomas. Arch Ophthalmol. 1977;95:63–69
  7. Wilder HC, Paul EV. Malignant melanoma of the choroid and ciliary body (a study of 2,535 cases). Mil Surg. 1951;109:370–378
  8. Fuchs E. Das Sarcom des Uvealtractus. Vienna: Wilhelm Braumuller; 1882;
  9. Knapp H. A treatise on intraocular tumors, from original clinical observations and anatomical observations. New York: Williams and Wood; 1869;
  10. Jackson E. A manual of the diagnosis and treatment of the diseases of the eye. 2nd ed. Philadelphia: Saunders; 1907;
  11. McLean IW, Foster WD, Zimmerman LE, Gamel JW. Modification of Callender’s classification of uveal melanoma at the Armed Forces Institute of Pathology. Am J Ophthalmol. 1983;96:502–509
  12. Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol. 1983;101:1894–1899
  13. Gamel JW, McLean IW, Foster WD, Zimmerman LE. Uveal melanomas (correlation of cytologic features with prognosis). Cancer. 1978;41:1897–1901
  14. McLean IW, Foster WD, Zimmerman LE. Uveal melanoma (location, size, cell type and enucleation as risk factors in metastasis). Hum Pathol. 1982;13:123–132
  15. McLean IW. Prognostic features of uveal melanoma. Ophthalmol Clin North Am. 1995;8:143–153
  16. Paul E, Parnell B, Fraker M. Prognosis of malignant melanomas of the choroid and ciliary body. Int Ophthalmol Clin. 1962;2:387–402
  17. Gamel JW, McLean IW, Greenberg RA, et al.  Computerized histologic assessment of malignant potential (a method for determining the prognosis of uveal melanomas). Hum Pathol. 1982;13:893–897
  18. Gamel JW, McLean IW. Computerized histopathologic assessment of malignant potential, II (a practical method for predicting survival following enucleation for uveal melanoma). Cancer. 1983;52:1032–1038
  19. Marcus DM, Minkovitz JB, Wardwell SD, Albert DM. The value of nucleolar organizer regions in uveal melanoma. Am J Ophthalmol. 1990;110:527–534
  20. Folberg R, Rummelt V, Parys–Van Ginderdeuren R, et al.  The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology. 1993;100:1389–1398
  21. McLean I, Keefe K, Burnier M. Uveal melanoma (comparison of the prognostic value of fibrovascular loops, mean of the ten largest nucleoli, cell type and tumor size). Ophthalmology. 1997;104:777–780
  22. Foss A, Alexander R, Jefferies L, Hungerford JL, Harris A, Lightman S. Microvessel count predicts survival in uveal melanoma. Cancer Res. 1996;56:2900–2903
  23. Collaborative Ocular Melanoma Study Group . Design and methods of a clinical trial for a rare condition: the Collaborative Ocular Melanoma Study. COMS report no. 3. Control Clin Trials. 1993;14:362–391
  24. Collaborative Ocular Melanoma Study Group. COMS manual of procedures, PB95–179693. Springfield, Virginia: National Technical Information Service, January 1995.
  25. Collaborative Ocular Melanoma Study Group. COMS study forms book, PB91–217315. Springfield, Virginia: National Technical Information Service, May 1991.
  26. Melia BM. Analysis of interrater agreement on an ordered categorical scale [abstract]. Control Clin Trials. 1990;11:275
  27. Melia BM, Albert D, Green R, Smith M. Evaluating the impact of a change in review committee membership in a multicenter trial [abstract]. Control Clin Trials. 1991;12:636
  28. Wells C, Bradford R, Fish G, Straatsma B, Hawkins B. Choroidal melanomas in American Indians. Arch Ophthalmol. 1996;114:1017–1018
  29. Collaborative Ocular Melanoma Study Group . Accuracy of diagnosis in the Collaborative Ocular Melanoma Study: COMS report no. 1. Arch Ophthalmol. 1990;108:1268–1273
  30. Grossniklaus H, Green W. Uveal tumors. In:  Garner A,  Klintworth G editor. Pathobiology of ocular disease (a dynamic approach). 2nd ed.. New York: Marcel Dekker; 1994;p. 1423–1477
  31. Scotto J, Fraumeni JF, Lee JAH. Melanomas of the eye and other noncutaneous sites. J Natl Cancer Inst. 1976;56:489–491
  32. Neugut A, Kizelnik-Freilich S, Ackerman C. Black-white differences in risk for cutaneous, ocular, and visceral melanomas. Am J Public Health. 1994;84:1828–1829
  33. Robertson D, Campbell R. Errors in the diagnosis of malignant melanoma of the choroid. Am J Ophthalmol. 1979;87:269–275
  34. Char D, Stone R, Irvine A, et al.  Diagnostic modalities in choroidal melanoma. Am J Ophthalmol. 1989;89:223–230
  35. Hungerford J. Management of ocular melanoma. Br Med Bull. 1995;51:694–716
  36. Shields J, McDonald P. Improvements in the diagnosis of posterior uveal melanomas. Arch Ophthalmol. 1974;91:259–264
  37. Margo C. The accuracy of diagnosis of posterior uveal melanoma. Arch Ophthalmol. 1997;115:432–433
  38. Fine S. In reply to: Margo C. The accuracy of diagnosis of posterior uveal melanoma. [letter]. Arch Ophthalmol. 1997;115:433–434
  39. McCartney A. Pathology of ocular melanomas. Br Med Bull. 1995;51:678–693
  40. Umlas J, Diener–West M, Robinson N, Green W, Grossniklaus H, Albert D. Comparison of transillumination measurements with histologic slide measurements in eyes with choroidal melanoma. Arch Ophthalmol. 1997;115:474–477
  41. Davidorf F, Lang J. The natural history of malignant melanoma of the choroid (small vs large tumors). Trans Am Acad Ophthalmol Otolaryngol. 1973;79:310–320
  42. Kidd M, Lyness R, Patterson C, Johnston P, Archer D. Prognostic factors in malignant melanoma of the choroid (a retrospective survey of cases occurring in Northern Ireland between 1965 and 1980). Trans Ophthalmol Soc UK. 1986;105:114–121
  43. Grossniklaus H, Albert D, Green W, Conway B, Hovland K, for the Collaborative Ocular Melanoma Study Group. Clear cell differentiation in choroidal melanoma. Arch Ophthalmol 1997;115:894–898.
  44. Shammas H, Blodi F. Peripapillary choroidal melanomas (extension along the optic nerve and its sheaths). Arch Ophthalmol. 1978;96:440–445
  45. Font R, Spaulding A, Zimmerman L. Diffuse malignant melanoma of the uveal tract (a clinicopathologic report of 54 cases). Trans Am Acad Ophthalmol Otolaryngol. 1968;72:877–895
  46. Cappin J. Malignant melanoma and rubeosis iridis. Br J Ophthalmol. 1973;57:815–824
  47. Starr H, Zimmerman L. Extrascleral extension and orbital recurrence of malignant melanomas of the choroid and ciliary body. Int Ophthalmol Clin. 1962;2:369–384
  48. Shammas H, Blodi F. Orbital extension of choroidal and ciliary body melanomas. Arch Ophthalmol. 1977;95:2002–2005
  49. Saornil M, Fisher M, Robertson D, Campbell R, et al.  Histopathologic study of eyes after iodine–125 episcleral plaque irradiation for uveal melanoma. Arch Ophthalmol. 1997;115:1395–1400
  50. Saornil M, Egan K, Gragoudas E, Seddon J, Walsh S, Albert D. Histopathologic findings of proton beam vs enucleated uveal melanoma. Arch Ophthalmol. 1992;110:1112–1118
  51. Coleman K. Prognostic value of morphometric features and the Callender classification. Ophthalmology. 1996;103:1634–1641
  52. Karlsson M, Boeryd B, Carstensen J, Kagedal B, Wingren S. DNA ploidy and S–phase fraction as prognostic factors in patients with uveal melanomas. Br J Cancer. 1995;71:177–181
  53. Hodge W, Duclos A, Rocha G, et al.  DNA index and S phase fraction in uveal malignant melanomas. Br J Ophthalmol. 1995;79:521–526
  54. Smith M, Liggett P, Rao N. Immunohistochemical characterization of lymphoid infiltration in human choroidal melanomas. ARVO abstracts. Invest Ophthalmol Vis Sci. 1988;29(3suppl):365
  55. Folberg R, Pe’er J, Gruman L, et al.  The morphologic characteristics of tumor blood vessels as a marker for tumor progression in primary human uveal melanoma (a matched case–control study). Hum Pathol. 1992;23:1298–1305
  56. Zimmerman L, McLean I. Changing concepts of the prognosis and management of small malignant melanomas of the choroid. Trans Ophthalmol Soc UK. 1975;95:487–494

 This work was supported under cooperative agreements EY06260, EY06284, and EY06887 with the National Eye Institute, which includes support from the National Cancer Institute, National Institutes of Health, Bethesda, Maryland; an unrestricted gift from Research to Prevent Blindness, Inc, New York, New York; and the Wisconsin Lions Eye Research Fund, Madison, Wisconsin.

PII: S0002-9394(98)00040-3

American Journal of Ophthalmology
Volume 125, Issue 6 , Pages 745-766 , June 1998